Biologics By Mckesson
UnclaimedPharmaceutical Preparation ManufacturingCary, NC
Founded
1994
Primary NAICS
325412
CAGE code
6LEB9
Federal awards
$682.7K
Overview
Biologics by McKesson supports oncology, rare disease, and cell and gene therapy with expert specialty pharmacy services patients and partners trust.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Drugs and Druggists' Sundries Merchant Wholesalers
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Justice | $286,308 | 1 |
| 2026 | Department of Veterans Affairs | $19,231 | 2 |
| 2025 | Department of Justice | $263,156 | 13 |
| 2025 | Department of Veterans Affairs | $116,585 | 3 |
| 2024 | Department of Justice | $21,536 | 1 |
| 2023 | Department of Justice | $11,702 | 1 |
| 2023 | Department of Veterans Affairs | -$15,444 | 3 |
| 2022 | Department of Veterans Affairs | -$20,366 | 4 |